Therapies and procedures
Radiofrequency ablation for bone tumors
With the OsteoCool™ system
Treating painful bone tumors
Pain relief in as few as three days1
Perform faster ablations with more procedural flexibility and power. The OsteoCool™ radiofrequency (RF) ablation system is cooled RF ablation technology. It treats painful bone tumors, including benign and painful metastatic lesions. The system’s algorithms are designed to perform optimally in bone, allowing you to overcome challenges through a wide range of ablation scenarios, letting you treat patients confidently and consistently.
OsteoCool™ 2.0 RF ablation system
The OsteoCool™ 2.0 RF ablation system helps you deliver optimal care for your patients, treating painful bone tumors with internally-cooled probes and now featuring faster ablations,†,2 four probes, and more power.3-5
OsteoCool™ clinical outcomes
The OsteoCool™ post-market clinical study (OPuS One) is a multicenter study that collected real-world evidence on the efficacy and safety of OsteoCool™ RF ablation. Twelve-month data show outcomes in 206 patients treated with OsteoCool™ RF ablation, including pain relief and improved quality of life in as little as three days.1
OsteoCool™ RF ablation system
OsteoCool™ is our legacy system for treating painful bone tumors.
† Bench testing may not be indicative of clinical results.
- Levy J, David E, Hopkins T, et al. Radiofrequency Ablation Provides Rapid and Durable Pain Relief for the Palliative Treatment of Lytic Bone Metastases Independent of Radiation Therapy: Final Results from the OsteoCool Tumor Ablation Post-Market Study. Cardiovasc Intervent Radiol. 2023;46(5):600-609. doi:10.1007/s00270-023-03417-x
- Based on internal data: ETR 30101200, OsteoCool™ 2.0 lesion validation test report, 20 samples. 2023.
- Clarivate Interventional Oncology Devices Market.
- Insights United States report, December 2022. Stryker OptaBlate™* RF generator system IFU 700001075365 Rev-AC.
- Merit MetaSTAR™* RF generator IFU 403321001_001.